Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Abbott Laboratories (ABT) – Abbott Laboratories Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Abbott Laboratories (ABT) trades at $84.30, down 3.11% on the day, with a bearish technical signal despite bullish oscillators. The company maintains strong fundamentals with $44.33B in 2025 revenue, 13.91% net income margin, and consistent dividend payments. Recent Q1 2026 earnings beat expectations at $1.15 EPS versus $1.14 expected, while analyst consensus remains strongly bullish with 31 buy ratings and a $124.64 price target representing 48% upside potential.
ABT presents a compelling value opportunity with attractive valuation metrics (P/E 23.62, P/S 3.27) and robust cash flow generation ($9.57B operating cash flow in 2025). Key risks include ongoing legal challenges from infant formula litigation and potential weakness in the Nutrition segment, though strong Medical Devices performance and institutional confidence support the long-term investment case.
Read full analysis

Key Stats

  • Market Cap
    $143.80B
  • Sector
    Health
  • 3M Drawdown
    -29.01%
  • Enterprise Value
    $170.56B
  • Dividend Yield
    3.05%
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    95 days
$83.56
52W Low: $82.57
11 May 2026
52W High: $138.08
24 Jun 2025

Abbott Laboratories (ABT) is currently valued at a market capitalization of $143.80B, with an enterprise value of $170.56B. Over the past 52 weeks, Abbott Laboratories has traded between a low of $82.57 and a high of $138.08, highlighting its annual price range. Over the past three months, Abbott Laboratories has recorded a drawdown of -29.01%, reflecting recent price volatility. Abbott Laboratories offers a dividend yield of 3.05%, with the most recent dividend of $0.63 paid on 15 Apr 26. On average, investors hold Abbott Laboratories for approximately 95 days, indicating typical investor behavior on the platform.

About Abbott Laboratories

Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.


Technical Indicators
|
|
|
Overall Summary
Bearish (4)Neutral (8)Bullish (15)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $143.80B
  • Sector
    Health
  • 3M Drawdown
    -29.01%
  • Enterprise Value
    $170.56B
  • Dividend Yield
    3.05%
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    95 days
$83.56
52W Low: $82.57
11 May 2026
52W High: $138.08
24 Jun 2025

Abbott Laboratories (ABT) is currently valued at a market capitalization of $143.80B, with an enterprise value of $170.56B. Over the past 52 weeks, Abbott Laboratories has traded between a low of $82.57 and a high of $138.08, highlighting its annual price range. Over the past three months, Abbott Laboratories has recorded a drawdown of -29.01%, reflecting recent price volatility. Abbott Laboratories offers a dividend yield of 3.05%, with the most recent dividend of $0.63 paid on 15 Apr 26. On average, investors hold Abbott Laboratories for approximately 95 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!